Human Papillomavirus detection by the Hybrid Capture II assay: A reliable test to select women with normal cervical smears at risk for developing cervical lesions

Diagnostic Molecular Pathology

Volumn 9, Issue 3, 2000, Pages 145-150

  Clavel, Christine ^a,b   Masure, Marie ^a   Levert, Marc ^a   Putaud, Isabelle ^a   Mangeonjean, Christelle ^a   Lorenzato, Marianne ^a   Nazeyrollas, Pierre ^a   Gabriel, René ^a   Quereux, Christian ^a   Birembaut, Philippe ^a  

^a Laboratoire Pol Bouin   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Cervical intraepithelial neoplasia; Cytologic screening; Human papillomavirus; Hybrid capture

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; FEMALE GENITAL TRACT INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; SCREENING TEST; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CHRONIC DISEASE; COLPOSCOPY; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS; VAGINAL SMEARS; VIRAL LOAD;

EID: 0033847305     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200009000-00004     Document Type: Article

References (29)

1. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?
2. Prevalence of Human Papillomavirus in Cervical Cancer: A Worldwide Perspective
3. Hybrid Capture II based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions
4. Hybrid Capture II, a new sensitive test for human papillomavirus detection
5. Human papillomavirus DNA testing in the management of cervical neoplasia
6. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance
7. HPV testing in primary screening of older women
8. Human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia
9. Human papillomavirus DNA genotypes: Prognostic factors for progression of cervical intraepithelial neoplasia
10. Natural history of cervicovaginal papillomavirus infection in young women
11. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
12. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia
13. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
14. Hybrid capture method for detection of human papillomavirus DNA in clinical specimens
15. Human papillomavirus infection of the cervix: Relative risk association of 15 common anogenital types
16. Identifying women with cervical neoplasia using Human Papillomavirus DNA testing for equivocal Papanicolaou results
17. HPV typing and testing in gynaegological pathology: Has the time come?
18. Human papillomaviruses detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods
19. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study
20. Comparison of PCR-and Hybrid Capture-based human papillomavirus detection using multiple cervical specimen collection strategies
21. Comparative evaluation of first- and second- generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer
22. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
23. Controversies in the management of low grade cervical intraepithelial neoplasia
24. Genital Human Papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction
25. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologicly normal cervical smears
26. Difference in prevalence of human papillomavirus genotypes in cytomorphologicly normal smears is associated with a history of cervical intraepithelial neoplasia
27. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide
28. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears
29. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types